top of page

Topic

Genetic Testing

8 Podcasts • 1 Course on BackTable

Hear how experienced physicians approach Genetic Testing on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering patient selection, workup, and procedure technique. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.

Navigating Shared Decision-Making in Bladder Cancer Treatment
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Urology

Episode # 308  •  11 Jun 2026

Navigating Shared Decision-Making in Bladder Cancer Treatment

What matters most to patients with non-muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology, Dr. Kelly Bree, Dr. Saum Ghodoussipour, and Meredith Donahue DNP join host Dr. Vignesh Packiam to discuss the power of shared decision-making across the NMIBC spectrum. They explore risk-adapted treatment selection, when to escalate or de-escalate therapy, and how to navigate conversations about recurrence risk, treatment burden, quality of life, and the possibility of cystectomy.

This podcast is supported by an educational grant from Johnson & Johnson.

More on Genetic Testing

Loading recent podcasts…

Urology

Urology # 308

Jun 11, 2026

with Dr. Kelly Bree, Meredith Donahue NP, Dr. Saum Ghodoussipour, Dr. Vignesh Packiam

Navigating Shared Decision-Making in Bladder Cancer Treatment

What matters most to patients with non-muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology,...

30+ listens

OBGYN

Women's Health # 119

Jun 2, 2026

with Dr. Andrei Rebarber, Dr. Nicole Faulkner

Single-Gene NIPT Explained: Clinical Applications & Benefits

How do you decide which noninvasive prenatal testing option is best for your patient, and when should you reach for...

260+ listens

Urology

Urology # 277

Nov 28, 2025

with Dr. Mark Tyson, Dr. Sarah Psutka, Dr. Vignesh Packiam

NMIBC Tumor Board: Upper Tract Challenges

One of the most common dilemmas in urologic oncology: what do you do when a patient has T1 disease in both the bladder...

1,100+ listens

Tumor Board

Tumor Board # 34

Nov 11, 2025

with Dr. Scott Genshaft, Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh, Dr. Alan Lee

Lung Cancer Tumor Boards: Multidisciplinary Approaches & Best Practices

As lung cancer treatments become more complex, is a collaborative tumor board more essential than ever? We’re kicking...

240+ listens

Tumor Board

Tumor Board # 65

Jun 11, 2026

with Dr. Kelly Bree, Meredith Donahue NP, Dr. Saum Ghodoussipour, Dr. Vignesh Packiam

Navigating Shared Decision-Making in Bladder Cancer Treatment

What matters most to patients with non-muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology,...

0+ listens

VI

Vascular & IR # 602

Dec 29, 2025

with Dr. Daniel DePietro, Dr. Venkatesh Krishnasamy

Managing Neuroendocrine Tumors in Interventional Radiology

What considerations drive your decision between bland embolization, TACE, and radioembolization in managing...

2,100+ listens

VI

Vascular & IR # 589

Nov 14, 2025

with Dr. Scott Genshaft, Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh, Dr. Alan Lee

Lung Cancer Tumor Boards: Multidisciplinary Approaches & Best Practices

As lung cancer treatments become more complex, is a collaborative tumor board more essential than ever? We’re kicking...

1,500+ listens

Tumor Board

Tumor Board # 31

Oct 7, 2025

with Dr. Mark Tyson, Dr. Sarah Psutka, Dr. Vignesh Packiam

NMIBC Tumor Board: Upper Tract Challenges

One of the most common dilemmas in urologic oncology: what do you do when a patient has T1 disease in both the bladder...

240+ listens

Multidisciplinary Approach to Non-Small Cell Lung Cancer

Tumor Board Course

2 CME/CE credits, 2.5 hours, 19 lessons

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page